| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Nov 24 | CCCC C4 Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 6.04 | 5,550 | 33.52 k | 221,862 |
| 7 Nov 24 | CCCC C4 Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 12,500 | 0.00 | 227,412 |
| 7 Nov 24 | CCCC C4 Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 12,500 | 0.00 | 35,000 |
| 16 Sep 24 | CCCC C4 Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 6.36 | 3,329 | 21.17 k | 214,912 |
| 16 Sep 24 | CCCC C4 Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 7,500 | 0.00 | 218,241 |
| 16 Sep 24 | CCCC C4 Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 7,500 | 0.00 | 47,500 |
| 30 May 24 | EDIT Editas Medicine | Stock Option (right to buy) Common Stock | Grant | Acquire A | No | No | 5.17 | 25,000 | 129.25 k | 25,000 |
| 15 Feb 24 | CCCC C4 Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 7.9 | 6,560 | 51.82 k | 210,741 |
| 14 Feb 24 | CCCC C4 Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 103,400 | 0.00 | 217,301 |
| 14 Feb 24 | CCCC C4 Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7.31 | 465,500 | 3.40 mm | 465,500 |
